Fazia Adyani Ahmad Fuad

Dr. Fazia Adyani Ahmad Fuad

International Islamic University Malaysia (IIUM)

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2020 in BioTech
Verified
Journal Article
Open access
PDF file
Suriyea TanbinSuriyea Tanbin
Suriyea Tanbin
FFFazia Adyani Ahmad Fuad
Fazia Adyani Ahmad Fuad
AHAzzmer Azzar Abdul Hamid
Azzmer Azzar Abdul Hamid
Dengue fever, which is a disease caused by the dengue virus (DENV), is a major unsolved issue in many tropical and sub-tropical regions of the world. The absence of treatment that effectively prevent further viral propagation inside the human’s body resulted in a high number of deaths globally each year. Thus, novel anti-dengue therapies are required for effective treatment. Human hexokinase II (HKII), which is the first enzyme in the glycolytic pathway, is an important drug target due to its significant impact on viral replication and survival in host cells. In this study, 23.1 million compounds were computationally-screened against HKII using the Ultrafast Shape Recognition with a CREDO Atom Types (USRCAT) algorithm. In total, 300 compounds with the highest similarity scores relative to three reference molecules, known as Alpha-D-glucose (GLC), Beta-D-glucose-6-phosphate (BG6), and 2-deoxyglucose (2DG), were aligned. Of these 300 compounds, 165 were chosen for further structure-based screening, based on their similarity scores, ADME analysis, the Lipinski’s Rule of Five, and virtual toxicity test results. The selected analogues were subsequently docked against each domain of the HKII structure (PDB ID: 2NZT) using AutoDock Vina programme. The three top-ranked compounds for each query were then selected from the docking results based on their binding energy, the number of hydrogen bonds formed, and the specific catalytic residues. The best docking results for each analogue were observed for the C-terminus of Chain B. The top-ranked analogues of GLC, compound 10, compound 26, and compound 58, showed predicted binding energies of −7.2, −7.0, and −6.10 kcal/mol and 7, 5, and 2 hydrogen bonds, respectively. The analogues of BG6, compound 30, compound 36, and compound 38, showed predicted binding energies of −7.8, −7.4, and −7.0 kcal/mol and 11, 9, and 5 hydrogen bonds, while the top three analogues of 2DG, known as compound 1, compound 4, and compound 31, showed predicted binding energies of −6.8, −6.3, and −6.3 kcal/mol and 4, 3, and 1 hydrogen bonds, sequentially. The highest-ranked compounds in the docking analysis were then selected for molecular dynamics simulation, where compound 10, compound 30, and compound 1, which are the analogues of GLC, BG6, and 2DG, have shown strong protein-ligand stability with an RMSD value of ±5.0 A° with a 5 H bond, ±4.0 A° with an 8 H bond, and ±0.5 A° with a 2 H bond, respectively, compared to the reference molecules throughout the 20 ns simulation time. Therefore, by using the computational studies, we proposed novel compounds, which may act as potential drugs against DENV by inhibiting HKII’s activity.

28 August 2019 in Microorganisms
Verified
Journal Article
Open access
PDF file
Foysal AhammadFoysal Ahammad
Foysal Ahammad
TRTengku Rogayah Tengku Abd Rashid
Tengku Rogayah Tengku Abd Rashid
MMMaizan Mohamed
Maizan Mohamed
STSuriyea Tanbin
Suriyea Tanbin
FFFazia Adyani Ahmad Fuad
Fazia Adyani Ahmad Fuad
FFFazia Ahmad Fuad
Fazia Ahmad Fuad
Dengue virus (DENV) is an arboviral human pathogen transmitted through mosquito bite that infects an estimated ~400 million humans (~5% of the global population) annually. To date, no specific therapeutics have been developed that can prevent or treat infections resulting from this pathogen. DENV utilizes numerous host molecules and factors for transcribing the single-stranded ~11 kb positive-sense RNA genome. For example, the glycosylation machinery of the host is required for viral particles to assemble in the endoplasmic reticulum. Since a variety of host factors seem to be utilized by the pathogens, targeting these factors may result in DENV inhibitors, and will play an important role in attenuating the rapid emergence of other flaviviruses. Many experimental studies have yielded findings indicating that host factors facilitate infection, indicating that the focus should be given to targeting the processes contributing to pathogenesis along with many other immune responses. Here, we provide an extensive literature review in order to elucidate the progress made in the development of host-based approaches for DENV viral infections, focusing on host cellular mechanisms and factors responsible for viral replication, aiming to aid the potential development of host-dependent antiviral therapeutics.

1 November 2021 in Molecules
Verified
Journal Article
Open access
PDF file
NSNurhainis Ogu Salim
Nurhainis Ogu Salim
FFFazia Adyani Ahmad Fuad
Fazia Adyani Ahmad Fuad
FKFarahayu Khairuddin
Farahayu Khairuddin
WSWan Mohd Khairulikhsan Wan Seman
Wan Mohd Khairulikhsan Wan Seman
MJmohd anuar Jonet
mohd anuar Jonet
Plasmodium lactate dehydrogenase (pLH) is one of the enzymes in glycolysis with potential target for chemotherapy. This study aimed to clone, overexpress and characterize soluble recombinant lactate dehydrogenase from Plasmodium knowlesi in a bacterial system. Synthetic P. knowlesi lactate dehydrogenase (Pk-LDH) gene was cloned into pET21a expression vector, transformed into Escherichia coli strain BL21 (DE3) expression system and then incubated for 18 h, 20 °C with the presence of 0.5 mM isopropyl β-d-thiogalactoside in Terrific broth supplemented with Magnesium sulfate, followed by protein purifications using Immobilized Metal Ion Affinity Chromatography and size exclusion chromatography (SEC). Enzymatic assay was conducted to determine the activity of the enzyme. SDS-PAGE analysis revealed that protein of 34 kDa size was present in the soluble fraction. In SEC, a single peak corresponding to the size of Pk-LDH protein was observed, indicating that the protein has been successfully purified. From MALDI-TOF analysis findings, a peptide score of 282 was established, which is significant for lactate dehydrogenase from P. knowlesi revealed via MASCOT analysis. Secondary structure analysis of CD spectra indicated 79.4% α helix and 1.37% β strand structure. Specific activity of recombinant Pk-LDH was found to be 475.6 U/mg, confirming the presence of active protein. Soluble Pk-LDH that is biologically active was produced, which can be used further in other malaria studies.

18 November 2022 in Processes
Verified
Journal Article
Open access
PDF file
FFFazia Adyani Ahmad Fuad
Fazia Adyani Ahmad Fuad
NSNurhainis Ogu Salim
Nurhainis Ogu Salim
Malaria management remains a challenge, due to the resistance of malaria parasites to current antimalarial agents. This resistance consequently delays the global elimination of malaria throughout the world. Hence, the demand is increasing for new and effective antimalarial drugs. The identification of potential drugs that target Pk-LDH can be obtained through virtual screening analyses, as this has been previously applied to discover Pf-LDH inhibitors. In this study, the selected candidates from our virtual screening analyses were subsequently tested against purified Pk-LDH, and verified through an inhibition of Pk-LDH via enzymatic activity assays. Virtual screening analysis from this study showed that 3,3-Difluoropyrrolidine hydrochloride and 3-hydroxytetrahydrofuran exhibited binding affinity values of −3.25 kcal/mol and −3.74, respectively. These compounds were selected for evaluation towards inhibitory activity against Pk-LDH assays, including two compounds from a previous study which are oxalic acid and glycolamide. The earlier compounds were structurally similar to lactate and pyruvate, and the latter two compounds were structurally similar to a known LDH inhibitor, oxamate. Among all of the compounds tested, oxalic acid showed the highest inhibition activity at 54.12%; interestingly, this correlated well with the virtual screening analyses, which showed that this compound was the best among the oxamate analogues, with a binding affinity value of −2.59 kcal/mol. Hence, further exploration and development of this compound may result in a promising antimalarial drug for malaria treatment, especially for infection involving P. knowlesi.

30 November 2022 in Journal of Advanced Research in Applied Sciences and Engineering Technology
Verified
Journal Article
Open access
PDF file
AAAisya Nazura Azman
Aisya Nazura Azman
SFsafwan Fathi
safwan Fathi
FFFazia Adyani Ahmad Fuad
Fazia Adyani Ahmad Fuad
RHRaden Shamilah Radin Hisam
Raden Shamilah Radin Hisam
NYNoor Azian Md. Yusuf
Noor Azian Md. Yusuf
Malaria is a parasitic infection caused by protozoan parasites from the genus Plasmodium. Over the years, various concerns have arisen regarding the efficacy in treating malaria caused by Plasmodium falciparum, which was reported to be caused by mutations in one of the parasite’s proteins, known as the Kelch 13 (K13). This study aims to generate the model structures of P.falciparum K13 protein mutants and to evaluate the binding affinities and interactions between these proteins and artemisinin drug, which is the drug used for the treatment of malaria. To date, the interactions between the protein mutants and artemisinin drug have not been computationally elucidated. In this study, four different types of mutant proteins were analysed, which are V494I, L598G, S600C and N537I and the results were compared with the wild-type K13 protein. Homology models of these proteins were created using the wild-type K13 (PDB ID:4YY8), with high percentage of sequence identity with the mutants. Most models with -2 and 2 have good Rama-Z scores, hence it can be deduced that the four mutants V494I (-1.21 ± 0.42), L598G (-1.19 ± 0.41), S600C (-0.93 ± 0.43), N537I (-1.16 ± 0.43) and the wild-type (-1.34 ± 0.45) have acceptable Rama-Z scores. Molecular docking between artemisinin and the generated models of K13 proteins revealed that all protein mutants have higher binding energy; V494I (-6.79 kcal/mol), L598G (-9.26 kcal/mol), S600C (-6.17 kcal/mol) and N537I (-6.96 kcal/mol), compared to the wild-type (-9.65 kcal/mol). The results showed that all four distinct mutant proteins have less stable complex formation, which indicate that the mutant proteins have higher resistance towards artemisinin due to the higher binding energy compared to the K13 wild-type protein. However, all mutations have a higher number of protein-ligand hydrophobic interactions and protein-ligand hydrogen bonds than the wild-type protein, which requires further analysis to understand the binding interactions. The predicted structural information with regards to binding interactions between the K13 mutant proteins and artemisinin obtained from this study has paved the path toward understanding how mutants may cause parasites’ resistance towards artemisinin drugs.

5 September 2018
Verified
Book Chapter
Open access
PDF file
YHYUMI ZUHANIS HAS-YUN Hashim
YUMI ZUHANIS HAS-YUN Hashim
HSHamzah Mohd. Salleh
Hamzah Mohd. Salleh
NPNoor Illi Mohamad Puad
Noor Illi Mohamad Puad
FFFazia Adyani Ahmad Fuad
Fazia Adyani Ahmad Fuad
MEMANAR EISSA
MANAR EISSA
NZNur Aimi Aliah Zainurin
Nur Aimi Aliah Zainurin
Herbal medicine is gaining acceptance worldwide for their effective pharmacological effects and relative safety. Plants have metabolic pathways that lead to the production and accumulation of secondary metabolites such as alkaloids, glycosides, and terpenoids that exhibit various biological activities. Plant secondary metabolites have been the major foci of investigation for several years and have been successfully used against a number of communicable and noncommunicable diseases such as diabetes, cancer, and viral infections. This chapter will explore Malaysian plants, their secondary metabolites, and their biological/medicinal properties with a particular focus on some selected species under a national project. Other aspects such as plant tissue culture to produce secondary metabolites and a case study on the use of secondary metabolites in the prevention and treatment of dengue fever are also described. While a lot of effort has been put in, further research and development into plant secondary metabolites are needed including using the plant tissue culture approach toward reaching high-value herbal industry.